156 related articles for article (PubMed ID: 8563186)
1. Ethanol potentiates valproic acid-induced neural tube defects (NTDs) in mice due to toxicokinetic interactions.
Elmazar MM; Nau H
Reprod Toxicol; 1995; 9(5):427-33. PubMed ID: 8563186
[TBL] [Abstract][Full Text] [Related]
2. Trimethoprim potentiates valproic acid-induced neural tube defects (NTDs) in mice.
Elmazar MM; Nau H
Reprod Toxicol; 1993; 7(3):249-54. PubMed ID: 8318756
[TBL] [Abstract][Full Text] [Related]
3. Methotrexate increases valproic acid-induced developmental toxicity, in particular neural tube defects in mice.
Elmazar MM; Nau H
Teratog Carcinog Mutagen; 1992; 12(5):203-10. PubMed ID: 1363493
[TBL] [Abstract][Full Text] [Related]
4. Contributions of dam and conceptus to differences in sensitivity to valproic acid among C57 black and SWV mice.
Beck SL
Reprod Toxicol; 1999; 13(5):353-60. PubMed ID: 10560583
[TBL] [Abstract][Full Text] [Related]
5. Exencephaly and axial skeletal malformations induced by maternal administration of sodium valproate in the MF1 mouse.
Padmanabhan R; Hameed MS
J Craniofac Genet Dev Biol; 1994; 14(3):192-205. PubMed ID: 7852547
[TBL] [Abstract][Full Text] [Related]
6. Valproic acid teratogenicity in mice after various administration and phenobarbital-pretreatment regimens: the parent drug and not one of the metabolites assayed is implicated as teratogen.
Nau H
Fundam Appl Toxicol; 1986 May; 6(4):662-8. PubMed ID: 3086173
[TBL] [Abstract][Full Text] [Related]
7. Teratogenic valproic acid concentrations: infusion by implanted minipumps vs conventional injection regimen in the mouse.
Nau H
Toxicol Appl Pharmacol; 1985 Sep; 80(2):243-50. PubMed ID: 3927520
[TBL] [Abstract][Full Text] [Related]
8. Effect of maternal exposure to homocystine on sodium valproate-induced neural tube defects in the mouse embryos.
Padmanabhan R; Shafiullah M; Benedict S; Nagelkerke N
Eur J Nutr; 2006 Sep; 45(6):311-9. PubMed ID: 16699836
[TBL] [Abstract][Full Text] [Related]
9. Valproic acid-induced neural tube defects in mouse and human: aspects of chirality, alternative drug development, pharmacokinetics and possible mechanisms.
Nau H; Hauck RS; Ehlers K
Pharmacol Toxicol; 1991 Nov; 69(5):310-21. PubMed ID: 1803343
[TBL] [Abstract][Full Text] [Related]
10. VPA-induced neural tube defects in mice. I. Altered metabolism of sulfur amino acids and glutathione.
Hishida R; Nau H
Teratog Carcinog Mutagen; 1998; 18(2):49-61. PubMed ID: 9704382
[TBL] [Abstract][Full Text] [Related]
11. Amidic modification of valproic acid reduces skeletal teratogenicity in mice.
Okada A; Kurihara H; Aoki Y; Bialer M; Fujiwara M
Birth Defects Res B Dev Reprod Toxicol; 2004 Feb; 71(1):47-53. PubMed ID: 14991910
[TBL] [Abstract][Full Text] [Related]
12. Valnoctamide, valpromide and valnoctic acid are much less teratogenic in mice than valproic acid.
Radatz M; Ehlers K; Yagen B; Bialer M; Nau H
Epilepsy Res; 1998 Mar; 30(1):41-8. PubMed ID: 9551843
[TBL] [Abstract][Full Text] [Related]
13. Amelioration of sodium valproate-induced neural tube defects in mouse fetuses by maternal folic acid supplementation during gestation.
Padmanabhan R; Shafiullah MM
Congenit Anom (Kyoto); 2003 Mar; 43(1):29-40. PubMed ID: 12692401
[TBL] [Abstract][Full Text] [Related]
14. Anticonvulsant profile and teratogenic evaluation of potent new analogues of a valproic acid urea derivative in NMRI mice.
Okada A; Noyori H; Yagen B; Shimshoni JA; Bialer M; Fujiwara M
Birth Defects Res B Dev Reprod Toxicol; 2009 Oct; 86(5):394-401. PubMed ID: 19830722
[TBL] [Abstract][Full Text] [Related]
15. Teratogenic effects of sodium valproate in mice and rats at midgestation and at term.
Menegola E; Broccia ML; Nau H; Prati M; Ricolfi R; Giavini E
Teratog Carcinog Mutagen; 1996; 16(2):97-108. PubMed ID: 8875740
[TBL] [Abstract][Full Text] [Related]
16. Effect of supplementation with folinic acid, vitamin B6, and vitamin B12 on valproic acid-induced teratogenesis in mice.
Elmazar MM; Thiel R; Nau H
Fundam Appl Toxicol; 1992 Apr; 18(3):389-94. PubMed ID: 1597263
[TBL] [Abstract][Full Text] [Related]
17. Mapping a chromosomal locus for valproic acid-induced exencephaly in mice.
Lundberg YW; Cabrera RM; Greer KA; Zhao J; Garg R; Finnell RH
Mamm Genome; 2004 May; 15(5):361-9. PubMed ID: 15170225
[TBL] [Abstract][Full Text] [Related]
18. Sodium valproate augments spontaneous neural tube defects and axial skeletal malformations in TO mouse fetuses [corrected].
Padmanabhan R; Ahmed I
Reprod Toxicol; 1996; 10(5):345-63. PubMed ID: 8888407
[TBL] [Abstract][Full Text] [Related]
19. Valproic acid-induced fetal malformations are reduced by maternal immune stimulation with granulocyte-macrophage colony-stimulating factor or interferon-gamma.
Hrubec TC; Yan M; Ye K; Salafia CM; Holladay SD
Anat Rec A Discov Mol Cell Evol Biol; 2006 Dec; 288(12):1303-9. PubMed ID: 17075842
[TBL] [Abstract][Full Text] [Related]
20. Myo-inositol enhances teratogenicity of valproic acid in the mouse.
Massa V; Wlodarczyk B; Giavini E; Finnell RH
Birth Defects Res A Clin Mol Teratol; 2006 Mar; 76(3):200-4. PubMed ID: 16511884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
